Daniel Faga
Interim CEO at AnaptysBio Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AnaptysBio Inc., 3 years.
AnaptysBio Inc.
Director · CEO
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2024 | AnaptysBio Inc. | Shares withheld for tax | −347,441 | $21.60 | $7,504,726 |
| Mar 25, 2024 | AnaptysBio Inc. | Open-market sale | −3,000 | $21.42 | $64,260 |
| Mar 22, 2024 | AnaptysBio Inc. | Open-market sale | −145,940 | $22.78 | $3,324,513 |
| Jan 8, 2024 | AnaptysBio Inc. | Open-market sale | −6,866 | $21.81 | $149,747 |
| Jan 6, 2024 | AnaptysBio Inc. | Option exercise | +17,850 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.